November 1, 2010 NuPathe Submits Zelrix NDA for the Treatment of Migraine Safeguard Scientifics’ partner company NuPathe submitted a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA). The NDA was filed for ZelrixTM,… Posted by James A. Datin
